Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
01/2008
01/30/2008EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines
01/30/2008CN101115728A Triazole substituted aminobenzophenone compounds
01/30/2008CN101115718A N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands
01/30/2008CN101113157A Isoamylene radical chromocor derivative, preparation method and uses thereof
01/30/2008CN101112608A Miao herb liniment for treating neck pain, shoulder pain, waist pain and leg pain
01/30/2008CN101112596A Chinese traditional medicine composition for treating postpartum tormina
01/30/2008CN101112590A Externally used medicine for treating rheumatism and rheumatism ache and method for preparing the same
01/30/2008CN101112562A Chinese traditional medicine composition for treating hyperosteogeny, protrusion of intervertebral disc and cervical vertebra ache
01/30/2008CN101112551A Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease
01/30/2008CN101112533A Chinese traditional medicine composition for treating and preventing gout and method of making the same
01/30/2008CN101112527A Oral Chinese traditional medicine composition for treating atrophic arthritis
01/30/2008CN101112519A Chinese traditional medicine preparations for treating postpartum tormina
01/30/2008CN101112518A Chinese traditional medicine preparations for treating postpartum blood deficiency and fever
01/30/2008CN101112503A Chinese traditional medicine composition and method of making the same
01/30/2008CN101112498A Chinese traditional medicine having functions of promoting blood circulation, relaxing vein and strengthening muscles and bones and method for preparing the same
01/30/2008CN101112488A Chinese herbal medicine for treating ankylosing spondylitis
01/30/2008CN101112482A Medicine for treating traumatic injury
01/30/2008CN101112480A Golden powder for treating wound
01/30/2008CN101112478A Powder medicine for treating hyperosteogeny
01/30/2008CN101112477A Externally-used Chinese traditional medicine compound preparations for treating pain of neck, shoulder, waist and legs
01/30/2008CN101112447A Chinese medicine composition for treating rheumatoid arthritis and method for preparing the same
01/30/2008CN101112430A Chinese traditional medicine composition for treating pantalgia after childbirth
01/30/2008CN101112423A Medicinal composition for needle and knife Chinese traditional medicine implantation therapy for treating pain of neck, shoulder, waist and legs
01/30/2008CN101112417A Rheum defervescence liniment and method for preparing the same
01/30/2008CN101112416A Quality control method of caulis spatho lobi particles
01/30/2008CN101112415A Compound milettia reticulata tablets and method for preparing the same
01/30/2008CN101112408A Sustained-release ji chrysanthemum tablet and method for preparing the same
01/30/2008CN101112380A Articular cavity inner injecting and administering preparations containing low-molecular-weight heparin or the low-molecular-weight heparin salt
01/30/2008CN101112378A Articular cavity inner injecting and administering reparations containing trehalose
01/30/2008CN101112337A Therapeutic equipment for cervical vertebra and lumbar vertebrae and method for preparing the same
01/30/2008CN100364988C Indazole having analgesic activity
01/30/2008CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors
01/30/2008CN100364612C Degraded agonist antibody
01/30/2008CN100364578C Plaster for treating facial palsy, rheumatism and prosopalgia and its production process
01/30/2008CN100364572C Chinese medicine preparation for treating old wound
01/30/2008CN100364568C Heat clearing and detoxicating pill containing vomiting nut
01/30/2008CN100364557C Method for preparing confervoide oil and medicine containing thereof
01/30/2008CN100364524C Freezing-drying sterile prepn. used for injection contg. sodium naproxen
01/30/2008CN100364521C Soft capsule composition containing acetaminophen
01/30/2008CN100364519C Chewing tablet of tramado hydrochloride and its preparation method
01/30/2008CN100364514C Biodegradable ocular implant
01/30/2008CN100364505C Fengshining drop pill for treating rheumatism and its preparation method
01/29/2008US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid
01/29/2008US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase
01/29/2008US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure
01/29/2008US7323471 Administering azathioprine, 6-mercaptopurine, or 6-thioguanine nucleotide, or their salts for treating graft-versus-host disease of the mouth; oral rinse
01/29/2008US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
01/29/2008US7323465 Alkansulfonamides as endothelin antagonists
01/29/2008US7323464 Kinase inhibitors; autoimmune disease; antiinflammatory agents
01/29/2008US7323442 Due to bacteria infections; administering lactoferrin
01/29/2008US7323316 Glycosyltransferase inhibitors
01/29/2008US7323170 Anti-CD80 antibodies
01/29/2008CA2451851C Use of pigment such as e.g. titanium dioxide for obtaining a special optical effect on oral medicament or food
01/29/2008CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids
01/29/2008CA2417455C Novel cyclooxygenase variants and methods of use
01/29/2008CA2406367C Method for treating pain by peripheral administration of a neurotoxin
01/29/2008CA2314170C Method of the prophylactic treatment of mastitis
01/29/2008CA2255620C Novel anandamide amidase inhibitors as analgesic agents
01/24/2008WO2008011487A2 L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
01/24/2008WO2008011485A2 Methods for treating chronic pain
01/24/2008WO2008011478A2 Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
01/24/2008WO2008011094A2 Cytokine induction of selectin ligands on cells
01/24/2008WO2008011085A1 Compositions and methods for the treatment of mucositis
01/24/2008WO2008011032A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
01/24/2008WO2008010601A1 NF- ϰB INHIBITOR
01/24/2008WO2008010511A1 Screening method
01/24/2008WO2008010448A1 Novel crystal of substituted phenylalkanoic acid and production process
01/24/2008WO2008010225A2 Enhancement of regulatory t cells' activity using statins
01/24/2008WO2008009954A1 Medical use of cyclin dependent kinases inhibitors
01/24/2008WO2008009758A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses
01/24/2008WO2008009735A1 Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors
01/24/2008WO2008009711A2 Use of soluble cd160 to suppress immunity
01/24/2008WO2008009665A1 Treatment of pain
01/24/2008WO2008009664A2 Treatment of pain
01/24/2008WO2008009663A1 Treatment of pain
01/24/2008WO2008009639A2 New indications for direct thrombin inhibitors
01/24/2008WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
01/24/2008WO2008009127A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
01/24/2008WO2007140439A3 Compounds as cannabinoid receptor ligands and uses thereof
01/24/2008WO2007139921A3 N-oxides of kappa opioid receptor peptides
01/24/2008WO2007122156A9 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
01/24/2008WO2007001975A8 Piperidine derivatives useful as histamine h3 antagonists
01/24/2008US20080022422 Chimeric pufa polyketide synthase systems and uses thereof
01/24/2008US20080021111 administering to a patient in need thereof an effective amount of fispemifene wherein said chronic nonbacterial prostatitis is not associated with urethral sphincter dysfunction
01/24/2008US20080021106 Cellular uptake of bioactive agents
01/24/2008US20080021100 Pharmaceutical Formulations and Compositions of a Selective Antagonist of Either CXCR2 or Both CXCR1 and CXCR2 and Methods of Using the Same for Treating Inflammatory Disorders
01/24/2008US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities
01/24/2008US20080021084 Derivatives Of Pyrazoline, Procedure For obtaining Them And Use Thereof As Therapeutic Agents
01/24/2008US20080021070 Pyridine derivatives, preparation and therapeutic application thereof
01/24/2008US20080021069 Receptor Function Regulating Agent
01/24/2008US20080021061 Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
01/24/2008US20080021058 Pyrazolo '3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) Inhibitors
01/24/2008US20080021057 3-Trifluoromethyl,6-((3-(methyl,4-hydroxytetrahydropyran-4-yl)-amino-(3-isopropyl-cyclopent-1,3-ylene))-carbonyl-)-5,6,7,8-tetrahydro-1,6-naphthyridine; antiinflammatory agents; immunomodulators; antiallergens; rhintis; dermatitis; conjunctivits, asthma; autoimmune diseases; antiarthritis agents
01/24/2008US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
01/24/2008US20080021042 Composition For Controlling Neuropathic Pain
01/24/2008US20080021039 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury
01/24/2008US20080021034 Compositions and methods for modulating gated ion channels
01/24/2008US20080021028 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis
01/24/2008US20080020998 Sustained release compositions for the therapeutic management of pain, inflammation and inflammation-associated disorders and prophylactic/ therapeutic methods thereof
01/24/2008US20080020985 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof